Protein glycation in diabetes as determined by mass spectrometry

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Lapolla, Annunziata ^a   Molin, Laura ^b   Traldi, Pietro ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Institute of Molecular Sciences and Technologies   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN A1; GLYCOSYLATED HEMOGLOBIN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; PROTEOME;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; ENZYME DEGRADATION; EXPERIMENT; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIMULATION; THERAPY; URINALYSIS;

EID: 84876575266     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/412103     Document Type: Review

References (43)

1. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
2. Maillard L. C., Action des acides aminés sur les sucres: formation des mélanoïdines par voie méthodique. Compte-Rendu De L'Académie Des Sciences 1912 66 68
3. Bucala R., Model P., Cerami A., Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proceedings of the National Academy of Sciences of the United States of America 1984 81 1 105 109 2-s2.0-0000571086 (Pubitemid 14180836)
4. Waris S., Pischetsrieder M., Saleemuddin M., DNA damage by ribose: inhibition at high ribose concentrations. Indian Journal of Biochemistry and Biophysics 2010 47 3 148 156 2-s2.0-77954284619
5. Lapolla A., Fedele D., Seraglia R., Catinella S., Baldo L., Aronica R., Traldi P., A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects. Diabetologia 1995 38 9 1076 1081 2-s2.0-0029089273 10.1007/s001250050394
6. Lapolla A., Fedele D., Aronica R., Garbeglio M., D'Alpaos M., Seraglia R., Traldi P., Evaluation of IgG Levels by matrix assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1997 11 12 1342 1346 (Pubitemid 27358297)
7. Clauser K. R., Baker P., Burlingame A. L., Role of accurate mass measurement (±10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Analytical Chemistry 1999 71 14 2871 2882 2-s2.0-0033565832 10.1021/ac9810516 (Pubitemid 29340480)
8. Hamdan M., Righetti P. G., Proteomics Today 2005 Hoboken, NJ, USA Jhon Wiley & Sons
9. Thiede B., Höhenwarter W., Krah A., Mattow J., Schmid M., Schmidt F., Jungblut P. R., Peptide mass fingerprinting. Methods 2005 35 3 237 247 2-s2.0-13844281502 10.1016/j.ymeth.2004.08.015 (Pubitemid 40255589)
10. Dass C., Fundamentals of Contemporary Mass Spectrometry 2007 Hoboken, NJ, USA Jhon Wiley and Sons
11. Lapolla A., Gerhardinger C., Baldo L., Fedele D., Keane A., Seraglia R., Catinella S., Traldi P., A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry. Biochimica et Biophysica Acta 1993 1225 1 33 38 2-s2.0-0027378298 10.1016/0925-4439(93)90118-K (Pubitemid 23348074)
12. Lapolla A., Fedele D., Seraglia R., Catinella S., Traldi P., Matrix-assisted laser desorption/ionization capabilities in the study of non-enzymatic protein glycation. Rapid Communications in Mass Spectrometry 1994 8 8 645 652 2-s2.0-0028483245 (Pubitemid 2129923)
13. Lapolla A., Baldo L., Aronica R., Gerhardinger C., Fedele D., Elli G., Seraglia R., Catinella S., Traldi P., Matrix-assisted laser desorption/ ionization mass spectrometric studies on protein glycation. 2. The reaction of ribonuclease with hexoses. Biological Mass Spectrometry 1994 23 5 241 248 2-s2.0-0028180247
14. Lapolla A., Fedele D., Aronica R., Baldo L., D'Alpaos M., Seraglia R., Traldi P., The in vitro glycation of lysozyme and the influence of buffer concentration investigated by mass spectrometry. Rapid Communication in Mass Spectrometry 1996 10 12 1512 1518 (Pubitemid 26368182)
15. Traldi P., Favretto D., Seraglia R., Lapolla A., Mass spectrometry in the study of non-enzymatic glyco-oxidation of proteins. Rapid Communication in Mass Spectrometry 1997 11 6 673 678 (Pubitemid 27284660)
16. Lapolla A., Fedele D., Aronica R., Garbeglio M., D'Alpaos M., Seraglia R., Traldi P., Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communication in Mass Spectrometry 1997 11 12 1342 1346 (Pubitemid 27358297)
17. Monnier V. M., The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging. The Biochemical Journal 2006 399 2 e11 e13 2-s2.0-33750129293 10.1042/BJ20061232
18. Szwergold B. S., Beisswenger P. J., Enzymatic deglycation-a new paradigm or an epiphenomenon? Biochemical Society Transactions 2003 31 6 1428 1432 2-s2.0-0347419265 (Pubitemid 38030993)
19. Conner J. R., Beisswenger P. J., Szwergold B. S., Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein. Annals of the New York Academy of Sciences 2005 1043 824 836 2-s2.0-23744457884 10.1196/annals.1333.095 (Pubitemid 41123977)
20. Delpierre G., Veiga-da-Cunha M., Vertommen D., Buysschaert M., Van Schaftingen E., Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes and Metabolism 2006 32 1 31 39 2-s2.0-33646087912 10.1016/S1262-3636(07)70244-6 (Pubitemid 43872593)
21. Mohás M., Kisfali P., Baricza E., Mérei A.., Maász A., Cseh J., Mikolás E., Szijártó I. A., Melegh B., Wittmann I., A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c levels and the onset of type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 2010 118 3 209 212 2-s2.0-77949505266 10.1055/s-0029-1238319
22. Mosca L., Penco S., Patrosso M. C., Marocchi A., Lapolla A., Sartore G., Chilelli N. C., Paleari R., Mosca A., Genetic variability of the fructosamine 3-kinase gene in diabetic patients. Clinical Chemistry and Laboratory Medicine 2011 49 5 803 808 2-s2.0-79954553174 10.1515/CCLM.2011.133
23. Marotta E., Lapolla A., Fedele D., Senesi A., Reitano R., Witt M., Seraglia R., Traldi P., Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides. Journal of Mass Spectrometry 2003 38 2 196 205 2-s2.0-0037295407 10.1002/jms.431 (Pubitemid 36305714)
24. Lapolla A., Fedele D., Reitano R., Aricò N. C., Seraglia R., Traldi P., Marotta E., Tonani R., Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. Journal of the American Society for Mass Spectrometry 2004 15 4 496 509 2-s2.0-1642544549 10.1016/j.jasms.2003.11.014 (Pubitemid 38407135)
25. Lapolla A., Fedele D., Aronica R., Garbeglio M., D'Alpaos M., Seraglia R., Traldi P., The in vivo glyco-oxidation of α-and β -globins investigated by matrix assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1996 10 9 1133 1135 (Pubitemid 26311566)
26. Lapolla A., Fedele D., Aronica R., Garbeglio M., D'Alpaos M., Plebani M., Seraglia R., Traldi P., A highly specific method for the characterization of glycation and glycooxidation products of globins. Rapid Communications in Mass Spectrometry 1997 11 6 613 617 (Pubitemid 27284649)
27. Lapolla A., Fedele D., Plebani M., Garbeglio M., Seraglia R., D'Alpaos M., Aricò C.N., Traldi P., Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1999 13 1 8 14 (Pubitemid 29032728)
28. Lapolla A., Fedele D., Plebani M., Aronica R., Garbeglio M., Seraglia R., D'Alpaos M., Traldi P., Evaluation of glycated globins by matrix-assisted laser desorption/ionization mass spectrometry. Clinical Chemistry 1999 45 2 288 290 2-s2.0-0033035029 (Pubitemid 29079131)
29. Hempe J. M., Gomez R., McCarter R. J., Chalew S. A., High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. Journal of Diabetes and its Complications 2002 16 5 313 320 2-s2.0-0036741885 10.1016/S1056-8727(01)00227-6
30. Lapolla A., Brioschi M., Banfi C., Tremoli E., Bonfante L., Cristoni S., Seraglia R., Traldi P., On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients. Journal of Mass Spectrometry 2008 43 1 74 81 2-s2.0-39149128004 10.1002/jms.1274 (Pubitemid 351251975)
31. Janke J., Engeli S., Boschmann M., Adams F., Böhnke J., Luft F. C., Sharma A. M., Jordan J., Retinol-binding protein 4 in human obesity. Diabetes 2006 55 10 2805 2810 2-s2.0-33750851422 10.2337/db06-0616 (Pubitemid 44923680)
32. Shea J., Randell E., Vasdev S., Wang P. P., Roebothan B., Sun G., Serum retinol-binding protein 4 concentrations in response to shortterm overfeeding in normal-weight, overweight, and obese men. American Journal of Clinical Nutrition 2007 86 5 1310 1315 2-s2.0-36248966629 (Pubitemid 350126232)
33. Chaurand P., Luetzenkirchen F., Spengler B., Peptide and protein identification by matrix-assisted laser desorption ionization (MALDI) and MALDI-post-source decay time-of-flight mass spectrometry. Journal of the American Society for Mass Spectrometry 1999 10 2 91 103 2-s2.0-0033374004 10.1016/S1044-0305(98)00145-7 (Pubitemid 34450221)
34. U.S. Renal Data System, URDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2001 Bethesda, Md, USA National Institute of Health, National Institutre of Diabetes
35. Gaede P., Vedel P., Parving H. H., Pedersen O., Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. The Lancet 1999 353 9153 617 622 2-s2.0-0033055724 10.1016/S0140-6736(98)07368-1 (Pubitemid 29087981)
36. Gorman D., Sochett E., Daneman D., The natural history of microalbuminuria in adolescents with type 1 diabetes. Journal of Pediatrics 1999 134 3 333 337 2-s2.0-0033509086 (Pubitemid 30417643)
37. Parving H. H., Chaturvedi N., Viberti G., Mogensen C. E., Does microalbuminuria predict diabetic nephropathy? Diabetes Care 2001 24 9 1560 1566 2-s2.0-0036479443
38. Caramori M. L., Fioretto P., Mauer M., The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000 49 9 1399 1408 2-s2.0-0033850165
39. Parving H. H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P., The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New England Journal of Medicine 2001 345 12 870 878 2-s2.0-0035922444 10.1056/NEJMoa011489
40. Rao P. V., Lu X., Standley M., Pattee P., Neelima G., Girisesh G., Dakshinamurthy K. V., Roberts C. T., Nagalla S. R., Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007 30 3 629 637 2-s2.0-33847691204 10.2337/dc06-2056 (Pubitemid 46354345)
41. Good D. M., Zürbig P., Argiles A., Bauer H. W., Behrens G., Coon J. J., Dakna M., Decramer S., Delles C., Dominiczak A. F., Ehrich J. H. H., Eitner F., Fliser D., Frommberger M., Ganser A., Girolami M. A., Golovko I., Gwinner W., Haubitz M., Herget-Rosenthal S., Jankowski J., Jahn H., Jerums G., Julian B. A., Kellmann M., Kliem V., Kolch W., Krolewski A. S., Luppi M., Massy Z., Melter M., Neusüss C., Novak J., Peter K., Rossing K., Rupprecht H., Schanstra J. P., Schiffer E., Stolzenburg J. U., Tarnow L., Theodorescu D., Thongboonkerd V., Vanholder R., Weissinger E. M., Mischak H., Schmitt-Kopplinr P., Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Molecular and Cellular Proteomics 2010 9 11 2424 2437 2-s2.0-78149291420 10.1074/mcp.M110.001917
42. Lapolla A., Seraglia R., Molin L., Williams K., Cosma C., Reitano R., Sechi A., Ragazzi E., Traldi P., Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. Journal of Mass Spectrometry 2009 44 3 419 425 2-s2.0-62149085888 10.1002/jms.1520
43. Molin L., Seraglia R., Lapolla A., Ragazzi E., Gonzalez J., Vlahou A., Schanstra J. P., Albalat A., Dakna M., Siwy J., Jankowski J., Bitsika V., Mischak H., Zürbig P., Traldi P., A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases. Journal of Proteomics 2012 75 18 5888 5897 10.1016/j.jprot.2012.07.024